Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients
mrt. 2017
K C J M, Kraal, et al
European Journal of Cancer
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma
sep. 2015
Gitta, Bleeker, et al
Cochrane Database of Systematic Reviews
Toxicity of upfront <sup>131</sup>I-metaiodobenzylguanidine ( <sup>131</sup>I-MIBG) therapy in newly diagnosed neuroblastoma patients
okt. 2013
Gitta, Bleeker, et al
European Journal of Nuclear Medicine and Molecular Imaging
The role of <sup>131</sup>I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
okt. 2013
Reineke A., Schoot, et al
European Journal of Nuclear Medicine and Molecular Imaging
